Literature DB >> 21688210

Compliance to continuous positive airway pressure therapy in a group of Portuguese patients with obstructive sleep apnea syndrome.

Claudia Alves1, José Manuel Pinto Chaves Caminha, Antonio Martins da Silva, Denisa Mendonça.   

Abstract

INTRODUCTION: Obstructive sleep apnea-hypopnea syndrome (OSAHS) is an emerging public health concern. Although different treatments for OSAHS had been proposed, continuous positive airway pressure (CPAP) is the first-line treatment in moderate to serious OSAHS in which success can be achieved by increasing compliance to CPAP.
MATERIALS AND METHODS: This study analyzes long-term CPAP compliance in patients with OSAHS on CPAP therapy for at least 1 month, who began CPAP therapy between January 2004 and December 2006, followed up at a Portuguese Sleep Outpatient Clinic in Santo António Hospital. Only effective data of CPAP use had been considered. During the first year of CPAP therapy, 96 patients were enrolled and followed up, but 15 patients had discontinued CPAP treatment. CPAP was used on average 5.1 h per day and in 80.1% of the total follow-up days. When compliance is defined as the use of CPAP for a minimum of 4 h per day in at least 70% of the follow-up days, only 54% of patients were classified as compliants during the first year. RESULTS AND
CONCLUSION: No statistically significant differences were found throughout the first year (p > 0.05) in terms of the percentage of compliants, controlling for demographic and clinic variables. None of the demographic and clinical baseline variables studied were found to be significant predictor of CPAP compliance (p > 0.05). This study diagnosed a low compliance to CPAP therapy in the studied sample, warning to the need of developing further studies in this area and to the need of implementing strategies to increase CPAP compliance.

Entities:  

Mesh:

Year:  2011        PMID: 21688210     DOI: 10.1007/s11325-011-0542-9

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  58 in total

1.  Vascular reactivity in obstructive sleep apnea syndrome.

Authors:  H W Duchna; C Guilleminault; R A Stoohs; J L Faul; H Moreno; B B Hoffman; T F Blaschke
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

2.  Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome.

Authors:  T Pieters; P Collard; G Aubert; M Dury; P Delguste; D O Rodenstein
Journal:  Eur Respir J       Date:  1996-05       Impact factor: 16.671

3.  Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin.

Authors:  S Saarelainen; J Lahtela; E Kallonen
Journal:  J Sleep Res       Date:  1997-06       Impact factor: 3.981

4.  Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.

Authors:  K Chin; K Shimizu; T Nakamura; N Narai; H Masuzaki; Y Ogawa; M Mishima; T Nakamura; K Nakao; M Ohi
Journal:  Circulation       Date:  1999-08-17       Impact factor: 29.690

5.  Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome.

Authors:  C Monasterio; S Vidal; J Duran; M Ferrer; C Carmona; F Barbé; M Mayos; N Gonzalez-Mangado; M Juncadella; A Navarro; R Barreira; F Capote; L R Mayoralas; G Peces-Barba; J Alonso; J M Montserrat
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

6.  [Compliance with nasal continuous positive airway pressure (CPAP) treatment in sleep apnea-hypopnea syndrome].

Authors:  A Alarcón; C León; A Maimó; F Barbé; A G Agustí; R Rodríguez-Roisin; A Granados; J M Montserrat
Journal:  Arch Bronconeumol       Date:  1995-02       Impact factor: 4.872

Review 7.  CPAP and behavioral therapies in patients with obstructive sleep apnea: effects on daytime sleepiness, mood, and cognitive function.

Authors:  Ana Isabel Sánchez; Pilar Martínez; Elena Miró; Wayne A Bardwell; Gualberto Buela-Casal
Journal:  Sleep Med Rev       Date:  2009-02-07       Impact factor: 11.609

8.  CPAP adherence and partial upper airway obstruction during sleep.

Authors:  Ulla Anttalainen; Tarja Saaresranta; Nea Kalleinen; Jenni Aittokallio; Tero Vahlberg; Olli Polo
Journal:  Sleep Breath       Date:  2007-09       Impact factor: 2.816

9.  Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; K E Cheshire; I J Deary; N J Douglas
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

10.  Nasal CPAP: an objective evaluation of patient compliance.

Authors:  M K Reeves-Hoche; R Meck; C W Zwillich
Journal:  Am J Respir Crit Care Med       Date:  1994-01       Impact factor: 21.405

View more
  15 in total

1.  Adherence to continuous positive airway pressure therapy in obstructive sleep apnea syndrome: effect of visual education.

Authors:  Ozen K Basoglu; Meltem Midilli; Rasit Midilli; Cem Bilgen
Journal:  Sleep Breath       Date:  2011-12-14       Impact factor: 2.816

2.  Prevalence, Associated Clinical Features, and Impact on Continuous Positive Airway Pressure Use of a Low Respiratory Arousal Threshold Among Male United States Veterans With Obstructive Sleep Apnea.

Authors:  Andrey Zinchuk; Bradley A Edwards; Sangchoon Jeon; Brian B Koo; John Concato; Scott Sands; Andrew Wellman; Henry K Yaggi
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

3.  Insomnia symptoms influence CPAP compliance.

Authors:  Christoph Pieh; Magdalena Bach; Roland Popp; Cecilia Jara; Tatjana Crönlein; Göran Hajak; Peter Geisler
Journal:  Sleep Breath       Date:  2012-02-04       Impact factor: 2.816

4.  Integrating sleep management into clinical practice.

Authors:  Catherine C Schuman; Hrayr P Attarian
Journal:  J Clin Psychol Med Settings       Date:  2012-03

5.  A Randomized Crossover Trial Evaluating Continuous Positive Airway Pressure Versus Mandibular Advancement Device on Health Outcomes in Veterans With Posttraumatic Stress Disorder.

Authors:  Ali A El-Solh; Gregory G Homish; Guy Ditursi; John Lazarus; Nithin Rao; David Adamo; Thomas Kufel
Journal:  J Clin Sleep Med       Date:  2017-11-15       Impact factor: 4.062

6.  A new characterization of adherence patterns to auto-adjusting positive airway pressure in severe obstructive sleep apnea syndrome: clinical and psychological determinants.

Authors:  Rute Sampaio; M Graça Pereira; João C Winck
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

Review 7.  A review of EPAP nasal device therapy for obstructive sleep apnea syndrome.

Authors:  Hao Wu; Xiandao Yuan; Xiaojun Zhan; Li Li; Yongxiang Wei
Journal:  Sleep Breath       Date:  2014-09-23       Impact factor: 2.816

8.  Effectiveness of a group education session on adherence with APAP in obstructive sleep apnea--a randomized controlled study.

Authors:  Filipa Soares Pires; Marta Drummond; Anabela Marinho; Rute Sampaio; Tiago Pinto; Miguel Gonçalves; Inês Neves; Cláudia Pinto; Maria Sucena; João Carlos Winck; João Almeida
Journal:  Sleep Breath       Date:  2012-11-23       Impact factor: 2.816

9.  Effect of Venlafaxine on Apnea-Hypopnea Index in Patients With Sleep Apnea: A Randomized, Double-Blind Crossover Study.

Authors:  Christopher N Schmickl; Yanru Li; Jeremy E Orr; Rachel Jen; Scott A Sands; Bradley A Edwards; Pamela DeYoung; Robert L Owens; Atul Malhotra
Journal:  Chest       Date:  2020-04-09       Impact factor: 10.262

10.  The clinical efficiency of positive airway pressure treatment.

Authors:  Sabri Koseoglu; Aykut Ikinciogullari; Mehmet Ali Cetin; Gokce Saygi Uysal; Rauf Oguzhan Kum; Berna Arli
Journal:  ScientificWorldJournal       Date:  2013-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.